An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research

被引:6
|
作者
Wang, Fa [1 ]
Johnson, Robert L. [2 ,5 ]
Snyder, Paul W. [2 ,3 ,7 ]
DeSmet, Marsha L. [4 ,6 ]
Fleet, James C. [1 ,3 ]
机构
[1] Purdue Univ, Dept Nutr Sci, 700 West State St, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA
[3] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA
[4] Purdue Univ, Interdisciplinary Life Sci PhD Training Program, W Lafayette, IN 47907 USA
[5] Eli Lilly & Co, Lilly Corp Ctr, 355 East Merrill St, Indianapolis, IN 46225 USA
[6] Indiana Univ, Dept Dermatol, Sch Med, 550 N Univ Blvd,Suite 3240, Indianapolis, IN 46202 USA
[7] EPL Inc, 45600 Terminal Dr 100, Sterling, VA 20166 USA
基金
美国国家卫生研究院;
关键词
Colorectal cancer; Transgenic animal model; Cre recombinase; Colitis; COLORECTAL-CANCER; ANIMAL-MODELS; FIELD CANCERIZATION; APC INACTIVATION; STEM-CELLS; EXPRESSION; CARCINOGENESIS; INFLAMMATION; EPITHELIUM; NEOPLASIA;
D O I
10.1007/s10620-015-3971-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Animal models are an important tool to understand intestinal biology. Our laboratory previously generated C57BL/6-Tg(Car1-cre)5Flt transgenic mice (CAC) with large-intestine-specific Cre recombinase (Cre) expression as a model to study colon health. To expand the utility of the CAC mouse model by determining the impact of chemically induced colitis on CAC transgene expression. CAC mice were crossed to Rosa reporter mice (Rosa26R (flox/flox) ) with a lox-STOP-lox signal controlling beta-galactosidase (beta gal) expression and then further crossed with Apc(CKO/CKO) mice in some experiments to delete Apc alleles (Apc (Delta 580) ). Initially, 8-week-old CAC(Tg/WT);Rosa26R (flox/WT) ;Apc (Delta 580/WT) mice were treated with dextran sulfate sodium (DSS) in drinking water (5 days, 0, 0.65, 1.35, or 2.0 %). Colon tissue damage and beta gal labeling were analyzed 10 day after stopping DSS. Next, 8-week-old CAC(Tg/WT);Rosa26R(flox/flox) mice were treated with 0 or 1.35 % DSS, and colonic beta gal labeling was assessed at 30 day post-DSS treatment. Finally, 10-week-old CAC(Tg/WT);Apc (Delta 580/WT) mice were treated with DSS (0 or 2 %) for 5 days and colonic tumors were analyzed at 20 weeks. CAC(Tg/WT);Rosa26R (flox/WT) ;Apc (Delta 580/WT) mice had a DSS dose-dependent increase in colon epithelial damage that correlated with increased epithelial beta gal labeling at 10 days (r (2) = 0.9, beta = 0.75). The beta gal labeling in CAC(Tg/WT);Rosa26R(flox/flox) mice colon remained high at 30 days, especially in the crypts of the healed ulcer. DSS also increased colon tumor incidence and multiplicity in CAC(Tg/WT);Apc (Delta 580/WT) mice. DSS-mediated epithelial damage induces a persistent, Cre-mediated recombination of floxed alleles in CAC mice. This enables the examination of gene function in colon epithelium during experimental colitis and colitis-induced colon cancer.
引用
收藏
页码:1069 / 1079
页数:11
相关论文
共 50 条
  • [21] Colitis in a transgenic mouse model of autoimmune uveitis may be induced by neoantigen presentation in the bowel
    C. Mölzer
    Y.-H. Liu
    E. Muckersie
    I. P. Klaska
    R. Cornall
    H. M. Wilson
    L. Kuffová
    J. V. Forrester
    Scientific Reports, 13
  • [22] Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer
    Seavey, Matthew M.
    Lu, Lily D.
    Stump, Kristine L.
    Wallace, Nate H.
    Hockeimer, William
    O'Kane, Teresa M.
    Ruggeri, Bruce A.
    Dobrzanski, Pawel
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 984 - 993
  • [23] Generation of a novel colon specific Cre-expressing transgenic mouse for colon cancer research
    Fleet, James
    Xue, Yingben
    Snyder, Paul
    CANCER RESEARCH, 2009, 69
  • [24] A genetic interval confers protection from colitis and colitis-associated cancer in a model of bacteria-induced colon cancer
    Kirchberger, S.
    Boulard, O.
    Royston, D.
    Maloy, K.
    Powrie, F.
    IMMUNOLOGY, 2010, 131 : 144 - 145
  • [25] Antioxidant Activity of Bovine Colostrum in the Colon of a Mouse Model of TNBS-Induced Colitis
    Leonardi, Leonardo
    Dib, Shadi
    Costanzi, Egidia
    Brecchia, Gabriele
    Traina, Giovanna
    ANTIOXIDANTS, 2025, 14 (02)
  • [26] Hepatocyte Growth Factor Inhibits Colon Cancer Development in a Mouse Model of Ulcerative Colitis
    Yamaji, Naohisa
    Ido, Akio
    Setoyama, Hitoshi
    Numata, Masatsugu
    Moriuchi, Akihiro
    Fujita, Hiroshi
    Sakiyama, Toshio
    Tsubouchi, Hirohito
    GASTROENTEROLOGY, 2011, 140 (05) : S815 - S815
  • [27] Dysbiosis of Gut Microbiota Increases Colon Cancer Risks in a Novel Mouse Model of Colitis
    Pramana, Abrory
    Liang, Siyuan
    Xu, Guanying
    Vazquez, Erick
    Pan, Yuan-Xiang
    Chen, Hong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S44 - S44
  • [28] Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer
    Xie, Yan
    Matsumoto, Hitoshi
    Nalbantoglu, ILKe
    Kerr, Thomas A.
    Luo, Jianyang
    Rubin, Deborah C.
    Kennedy, Susan
    Davidson, Nicholas O.
    PLOS ONE, 2013, 8 (06):
  • [29] Generation of a novel colon-specific Cre-expressing transgenic mouse for colon cancer research
    Fleet, James
    Xue, Yingben
    Snyder, Paul
    CANCER RESEARCH, 2009, 69
  • [30] Generation of a Novel Colon-Specific Cre-Expressing Transgenic Mouse for Colon Cancer Research
    Xue, Yingben
    Snyder, Paul W.
    Fleet, James C.
    GASTROENTEROLOGY, 2009, 136 (05) : A6 - A6